The use of live, attenuated bacteria as vaccine delivery sys tems for heterologous antigens has been extensively studied. In particular, attenuated Salmonella strains have been modified to express a wide range of antigens from bacterial, parasitic, and viral sources (reviewed in references 20, 29, and 41) . A fter oral adm inistration, Salmonella can penetrate the Peyer's patches via M cells and colonize the mesenteric lymph nodes, which contain various antigen-presenting cells (reviewed in reference 5). This can generate a range of immune responses, including systemic and mucosal responses at local and distal sites. O ther advantages of using attenuated Salmonella include the ease of oral adm inistration, which bypasses the need for needle adm inistration; increased antigen presentation due to the use of a live-vector delivery system, the induction of both T h l and Th2 immune responses; and the wide range of atten uated Salmonella and recom binant vectors available to re searchers (19, 20, 51) .
However, there are a num ber of issues to overcome. Most m ethods for the expression of heterologous antigens in Salmo nella use plasmids to express the antigenic proteins. This can have several drawbacks. The stable m aintenance of the expres sion plasmid in vivo can be difficult to achieve. Tightly regu lated prom oters are often used to increase plasmid stability, and several in vivo-inducible prom oters have delivered prom ising results. O ral delivery of flroTD -attenuated Salmonella enterica serovar Typhimurium expressing the C fragm ent of tetanus toxin from nirBp was able to protect mice from lethal tetanus challenge (6) . O ther in vivo-inducible prom oters, such as pagCp, sspAp, and ssaGp, have also been used in aroADattenuated S. enterica serovar Typhimurium to generate te ta nus toxoid-specific and heat-labile toxin B immune responses in mice (12, 35, 48) .
Instability may arise through the extra metabolic burden associated with a high-copy-number plasmid, leading to the selection of variants th at have lost the plasmid during growth. In vitro, plasmids can be m aintained through the use of anti biotic resistance markers; however, this is not feasible under field conditions, with emerging antibiotic resistance a global health issue. In order for these vaccines to be used in a com mercial human or veterinary setting, the antibiotic resistance genes m ust be removed, although a selection mechanism for the m aintenance of plasmids during vaccine production would still be required (48) . One m ethod for nonantibiotic m ainte nance of plasmid vectors is the use of the asd vector/A.asd host lethality system, in which the attenuated S. enterica serovar Typhimurium has an obligatory requirem ent for diaminopimelic acid that is com plem ented by the vector (39) . N on antibiotic resistance markers have also been developed, including bar, which encodes resistance to the herbicide DL-phosphinothricin (38) ; merA, which provides resistance to organomercurial compounds (21) ; and arsAB, which express arsenite resis- tance proteins (9) . Plasmid-based expression (PBE) systems can express antigens at high levels; however, high levels of expression of some antigens can have a growth-inhibitory effect (10, 51) and thus can reduce the eflhcacy of the live delivery system. To overcome some of the problems associated with PBE systems, heterologous antigen expression cassettes have been integrated into the Salmonella chromosome (25, 47) . The chromosomally integrated constructs have been examined as vac cines in several studies and were shown to elicit a protective immune response, although generally the level of antigen ex pression is much lower than in plasmid-based systems (20) .
In this study, we used two Mycoplasma hyopneumoniae an tigens, F2P97 (hereafter referred to as Adh) and ribonucleotide reductase (NrdF), in a screen to identify novel prom oters use ful for antigen expression in S. enterica serovar Typhimurium from single-copy chromosom al constructs. M. hyopneumoniae is a pathogen of swine that colonizes the ciliated epithelial cells of the respiratory tract and causes significant economic losses (11) . Adh and N rdF have both been previously studied in vaccination experiments when expressed from plasmid-based systems in S. enterica serovar Typhimurium aroA (7, 8, 15, 16, 17) . O ral vaccination with NrdF-expressing S. enterica serovar Typhimurium aroA has resulted in significant immunoglobulin A (IgA) responses in murine lungs (16) , increased murine splenocyte NrdF-specific gamma interferon (IFN-y) produc tion (7), and prim ed the porcine respiratory tract for an N rdFspecific secretory IgA response (17) . Adh-stim ulated splenocytes from mice orally vaccinated with S. enterica serovar Typhimurium aroA expressing Adh showed increased IFN-y production (8 ) . The constructs generated in this study, which expressed both antigens in tandem , were used to orally vacci nate mice, and the immune responses were evaluated.
MATERIALS AND METHODS
Growth of bacterial strains and isolation of genomic and plasmid DNA. The bacterial strains and plasmids used in this study are listed in Table 1 . M. hyo pneumoniae was grown in Friis medium as previously described (18) . Escherichia coli and S. enterica serovar Typhimurium strains were grown in Luria-Bertani (LB) medium supplemented with antibiotics, where appropriate, at 37°C. Anti biotics were used at the following concentrations: ampicillin, 100 jxg/ml; chlor amphenicol, 50 |xg/ml: kanamycin, 50 pg/nil: rifampin (rifampicin), 100 fxg/nil; and streptomycin, 100 fxg/nil. Growth curve analysis with minimal medium sup plemented with aromix was performed as previously described (33) .
Plasmid DNA was isolated using the Wizard Plus SV Miniprep kit (Promega, Australia) according to the manufacturer's instructions. Isolation of genomic DNA was achieved using the DNeasy Blood and Tissue Kit (Qiagen, Australia) according to the manufacturer's instructions.
For protein expression, His6-tagged Adh (27) and NrdF (16) expression vec tors were used. E. coli cultures were grown to an optical density at 560 run (OD560) of 0.8 at 37°C, induced with isopropyl thiogalactopyranoside at a final concentration of 1 mM, and grown for a further 4 h. The cells were pelleted at 5,000 X g for 10 min, and the recombinant protein was purified using nickelnitrilotriacetic acid resin (Qiagen) as specified in the manufacturer's instructions. Construction of recombinant plasmids. Restriction enzyme digestions and DNA ligations were performed according to standard procedures (43) . To con struct pJLA507-AN, nrdF was PCR amplified from M. hyopneumoniae strain J DNA using the primers 5,-GGCATATGGATCTATTATATAAACTAATT-3/ and 5 '-GGGTCGACTTAAAACTCCCAATCTTCATG-3'. This PCR product encompassed the DNA encoding the 11-kDa carboxy terminus of NrdF. The adh gene was PCR amplified from M. hyopneumoniae strain J DNA using the primers 5' -GGCAT AT G AAATTAG ACG AT AAT CTT CAG-3' and 5 '-GGGT CG ACT TAAGGATCACCGGATTTTGAA-3'. This PCR product encompassed the DNA encoding an approximately 36-kDa segment of P97 incorporating both C-terminal repeat regions and is referred to as Adh. The PCR products and pJLA507 were digested with Ndel and Sail, ligated, and transformed into E. coli JM109. Potential clones were screened using digoxigenin (Dig)-labeled probes in a colony hybridization screening procedure according to the manufacturer's instructions (Roche, Australia). Plasmid pJLA507-A was then digested with Xhol and Sail to release the adh gene, which was then subcloned into the Sail site of pJLA507-N to yield pJLA507-AN. To construct pARS-AN, pJLA507-AN was digested with EcoRI and Hindlll to release the nrdF-adh operon, which was then subcloned into pUClSNotl to create pUC18NotI-AN. Plasmid pUC18NotI-AN was digested with Notl, and the nrdF-adh operon was cloned into the Notl site of pUT/Ars (24) to form pARS-AN and subsequently trans formed into E. coli CC118 Xpir (Fig. 1) .
Construction of the sspA chromosomal expression strain began with digesting pJLA507-AN with Ncol and H indlll and then subcloning the promoterless nrdF-adh operon into the Ncol and H indlll sites of pKKsspATetC to form pKKsspA-AN. The region from sspAp to the rmB terminator sequence (includ ing the nrdF-adh operon) was PCR amplified using primers 5'-GTCGAAAGC TT GTCGACTT AAGGA-3' and 5' -G ACT CCCATGG AT CT ATT AT AT AAAC T-3'. pCVDaroDins was digested with SphI and SacI, and the PCR product was ligated into these sites to form pCVD-AN.
PCR amplification of the nrdF-adh operon for screening purposes was perform ed using 5' -G GC AT AT G GAT CT ATT AT AT AAACT AATT-3' and 5' -GGGTCG ACTT AAGGAT CACCGGATTTT GAA-3'.
Conjugation and arsenic resistance screening. pARS-AN was transformed into E. coli SM10 Xpir. S. enterica serovar Typhimurium STM-1 was mated with SM10 X/?ir(pARS-AN) overnight on LB agar at 37°C. Prior to being plated onto 1820 M A TIC E T AL. As(III)-resistant colonies were then selected on LB agar plates supplemented with streptomycin, 100 pM 2,2' bipyridyl, and 2 mM As(III) for 96 h at 37°C. To discriminate between genuine transposition events and illegitimate recombina tion events, arsenite-resistant colonies were screened for the loss of the ampicillin resistance marker by examining sensitivity to ampicillin.
Conjugation of pCVD-AN into S. enterica serovar Typhimurium JA08 (a rifampin-resistant, streptomycin-sensitive derivative of STM-1) was performed as previously described (48) . Selection for double crossovers using lacZ color se lection was performed as previously described (48) . The double crossovers were confirmed via PCR, and the double-crossover strain was desiguated STM-sspA.
Colony immunoblotting screening for antigen expression. Colony irnmunoblotting was performed essentially as previously described (43) . The colonies to be screened were picked and patched onto the appropriate agar plates and grown overnight at 37°C. The colonies were lifted onto a nitrocellulose membrane. The nitrocellulose was exposed to chloroform vapor for 15 min in an airtight glass container. The colonies were lysed overnight at room temperature with gentle agitation in lysis buffer (100 mM Tris-HQ, pH 7.8,150 mM NaCl, 5 mM MgQ2, 1 pg/ml DNase I, 40 pg/ml lysozyme). The nitrocellulose membranes were then washed twice for 30 min each time in phosphate-buffered saline (PBS) (8 g/liter N a d , 0.2 g/liter KC1, 1.15 gditer Na2H P 0 4, 0.2 gditer KH2P 0 4) and blocked with PBS-5% skim milk for 1 h at room temperature with gentle agitation. The primary antibody was diluted 1:1,000 in PBS-1% skim milk and applied to the membranes for 2 to 4 h at room temperature with gentle agitation. The mem branes were then washed three times in PBS for 10 min per wash, and the appropriate secondary antibody was diluted 1:1,000 in PBS-1% skim milk. The membrane was incubated with the secondary-antibody solution for 2 h at room temperature with gentle agitation, followed by three 10-min washes in PBS. The membrane was equilibrated in 100 mM Tris-HCl (pH 7.6) for 2 min and devel oped in diaminobenzidene developing solution (50 mg diaminobenzidine, 50 ml Tris-HCl, pH 7.6, 30 pi H20 2) until sufficient color was obtained. The reaction was then stopped by immersing the membrane in distilled H20 .
Inverse PCR and Southern hybridization analyses. Chromosomal DNA was isolated from S. enterica serovar Typhimurium strains using the DNeasy Blood and Tissue Kit (Qiagen, Australia) according to the manufacturer's instructions. DNA was digested with the appropriate restriction enzymes (Fermentas, Aus tralia), followed by heat inactivation according to the manufacturer's instruc tions. Chromosomal DNA was then religated overnight in a final volume of 100 pi as described previously. Inverse PCR was then performed using the primer sequences 5 '-TCAATTAGTTTATATAATAGATCC-3' and 5'-TTAGTCAAT TATCGGCTCG-3', which were outward-facing sequences based on the adh and nrdF genes, respectively. The PCR products were DNA sequenced as previously described (37) .
Southern transfer was performed as previously described (43) . Dig-labeled nrdF PCR products were used as probes, and Southern hybridization analysis was performed according to the manufacturer's instructions (Roche, Australia).
Induction of PBE strains and expression stability. S. enterica serovar Typhi murium STM-1 strains harboring the pJLA507 series of constructs were grown in a 10-ml LB starter culture overnight at 37°C. The entire starter culture was used to inoculate a 50-ml LB culture, and the OD560 was adjusted to 0.4 with LB. The strains were grown for 1 h at 37°C. Induction was achieved by culturing the strains at 42°C. Growth curves in minimal medium supplemented with aromix were performed as previously described (33) .
SDS-PAGE and Western blot analyses. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels were run as described by Sambrook et al. (43) and stained with Coomassie brilliant blue. For Western blot analysis, SDS-PAGE gels were electrophoresed but not stained. The samples were nor malized by culture amount and visual analysis on Coomassie-stained SDS-PAGE so that equivalent amounts were loaded in each lane. Western transfer and membrane blotting were performed as previously described (15) . The membrane was then developed in diaminobenzidene developing solution (50 mg diamino benzidine, 50 ml Tris-HCl, pH 7.6, 30 pi H20 2) until sufficient color was ob tained. The reaction was then stopped by immersing the membranes in distilled H20 . Alternatively, membranes were developed using a SuperSignal West Pico chemiluminescent substrate kit (Pierce, Australia) according to the manufactur er's instructions. For pooled sera, the highest-responding mouse in each chromosomally based expression (CBE)-immunized group (as determined by en zyme-linked immunosorbent assay [ELISA] IgG response against Adh) was selected. Equal volumes of sera from these mice were then pooled, diluted 1:50, and used in Western blot analysis.
Animal immunization procedures. Six-week-old female BALB/c mice were caged separately according to treatment groups (10 mice per group). For live oral vacci nations, CBE cultures were grown to an OD560 of 1.0 and pelleted at 5,000 X g for 10 min. PBE cultures were induced at 42°C for 4 h and pelleted at 5,000 X g for 10 min. All oral vaccination strains were then resuspended in ice-cold PBS with 5% sucrose to an OD corresponding to 1 X 109 viable cells per 100 pi. The mice were deprived of drinking water for 3 h prior to oral immunization. After 3 h, the mice were orally immunized with a single 100-pi dose containing 1 x 109 viable cells delivered behind the incisors using a pipette tip. For intraperitoneal immuniza tion, 50 pg of purified Adh or NrdF was diluted to a total volume of 50 pi in PBS and then mixed with an equal volume of Freund's incomplete adjuvant. The mice were then immunized with a 100-pi dose.
A total of three immunizations were performed for both the oral and intra peritoneal groups, each given 2 weeks apart. Two weeks after the final immuni zation, five mice in each group were euthanized with C 0 2 and exsanguinated by severing the brachial artery (day 42). Sera were collected and stored at -20°C. Lung wash samples were taken using 500 pi PBS containing 2 pM phenylmethylsulfonyl fluoride and stored at -20°C. The remaining five mice in each group were given an intranasal antigen challenge 2 weeks later (day 56) consisting of 5 pg of Adh and 5 pg of NrdF in PBS (total volume, 10 pi). These mice were exsanguinated as described above 2 weeks after antigen challenge (day 70).
The generation of rabbit polyclonal NrdF and Adh antisera was performed as previously described (31) .
To determine the in vivo stability of the STM-1 strains, five mice per group were orally inoculated with 1 X 109 CFU as described above. Ten days after inoculation, the mice were exsanguinated as described above and the spleens were removed. The spleens were homogenized in 5 ml ice-cold PBS and plated onto LB-rifampin (STM-sspA) or LB-streptomycin (all other strains). The total CFU were calculated, and 50 colonies (10 colonies per mouse) were randomly selected for further analysis. Southern blotting was performed as described above using a Dig-labeled nrdF probe to detect the presence of the operon. Western blotting was performed as described above with rabbit polyclonal Adh antisera.
ELISA protocols and statistical analysis. ELISA was performed as previously described (16) , and the results were analyzed using Softmax Pro 4.0 software (Molecular Devices, Australia). For whole-cell ELISA, STM-1 was streaked onto an agar plate and grown overnight at 37°C. A single colony was then used to inoculate 10 ml of LB and was grown in a 37°C shaking incubator until an OD600 of 1 was reached. The cells were pelleted at 5,000 X g for 10 min at 4°C, and the supernatant was discarded. The pellet was then resuspended in 10 ml of PBS-10% methanol. The cells were dispensed into 1-ml aliquots and stored at -20°C until they were required. The cells were thawed on ice, and 96-well ELISA plates (Interpath, Australia) were then coated with 50 pi of cells per well. The 96-well plates were centrifuged at 420 X g for 10 min at room temperature. The solution in the wells was removed, and the plates allowed to air dry. The plates were then blocked, incubated, and developed as described above.
Statistical significance was determined using a Student t test by comparison of each trial group to the PBS-negative control group. A P value of <0.05 was considered to be significant.
RESULTS
Construction of PBE strains. The goal of this study was to identify prom oters useful for antigen expression in S. enterica serovar Typhimurium. We devised a genetic screen using two M. hyopneumoniae antigens, Adh (F2P97) and NrdF. The adh gene encodes a domain containing both repeat regions of P97 (27) . P97 is a proteolytically processed adhesin protein capable of binding swine cilia (11, 53) . N rdF has been extensively studied as a putative vaccine candidate, and previous vaccina tion studies have dem onstrated that N rdF can invoke T h l and Th2 immune responses and improve the average daily weight gain of swine challenged with M. hyopneumoniae (7, 16, 17) .
The cloning scheme of the PBE constructs is outlined in Fig.  1 . NrdF and adh antigens were PC R amplified from M. hyo pneumoniae chromosom al D N A and flanked with N del and Sail restriction sites, which facilitated cloning into pJLA507 to produce pJLA507-A (containing adh) and pJLA507-N (con taining nrdF). The pJLA507-A vector was digested with X hol/ Sail, and adh was subcloned into the Sail site of pJLA507-N to produce pJLA507-AN. Plasmid pJLA507-AN is capable of ex pressing both antigens as individual proteins from the tem per ature-inducible PLPR prom oter (45) .
Construction of CBE strains. In order to attain antigen expression from single-copy non-antibiotic-resistant chrom o somal constructs in S. enterica serovar Typhimurium, CBE systems were engineered. Initially the prom oterless nrdF-adh operon from pJLA507-AN was subcloned into pUC18/Vof, which flanked the nrdF-adh operon with N otl sites. Plasmid pUC18N otI-A N was digested with N otl, and the nrdF-adh operon was subcloned into pU T/A rs to produce pARS-AN (Fig. 1) . Plasmid pA RS-A N was then transform ed into SM10 Xpir, and a prom oter-trapping experim ent was perform ed whereby SM10 Xpir(pARS-AN) was m ated with S. enterica serovar Typhimurium STM-1. A total of 1,200 arsenite-resistant, ampicillin-sensitive STM-1 transconjugants were screened for the expression of A dh via colony immunoblotting (results not shown), and four highly expressing transconjugants were selected for further characterization. The presence of the nrdFadh operon in the chromosomes of arsenite-resistant, Adhexpressing STM-1 colonies was confirmed using PCR and Southern hybridization analyses (Fig. 2) .
To construct the sspA chromosom al expression strain, pJFA507-AN was digested with N col and H in d lll, and the prom oterless nrdF-adh operon was subcloned into the N col and H in d lll sites of pKKsspA to form pKKsspA-AN. The region from psspA to irnBt, including the nrdF-adh operon, was PCR amplified and flanked with SphI and SacI sites. pCV D aroDins was digested with SphI and SacI, and the PCR product was cloned between these sites to form pCV D -AN (Fig. 1) . pCV D -AN was transform ed into E. coli S17.1 Xpir and m ated with STM-1 JA08. D ouble crossovers were selected using lacZ color screening, putative double crossovers were confirmed via PCR (Fig. 2) , and a selected strain was designated STM-sspA.
Characterization of STM-1 expression strains. Inverse PCR was perform ed to examine the insertion point of the nrdF-adh operon in the chromosome of STM-1 to determ ine which p ro moters were driving antigen expression. Once inverse-PCR products were generated, D N A sequence analysis was used to determ ine the point of insertion (Fig. 2) . Briefly, expression of N rdF and Adh in STM-AN1 was under the control of the dps prom oter. The dps gene encodes a D N A binding protein, which provides starvation-induced resistance to hydrogen p e r oxide (22) . In STM-AN2, the nrdF-adh operon has been inserted into the glycogen metabolism operon, namely, the glycogen phosphorylase gene,glgP (2) . In STM-AN4, the nrdFadh operon has been inserted into a gene required for conjugal transfer, tral.
D N A sequence analysis of the inverse-PCR product ob tained for STM-AN3 revealed that the construct had been inserted into a novel D N A sequence that showed no homology to any known Salmonella genome sequence. In order to con firm the existence of this novel sequence in STM-1, PC R prim ers were designed based on the sequence, and a PCR product was amplified from the genome of the original parental strain, STM-1 (data not shown). The PCR product was sequenced and was a 100% match to the original inverse-PCR product from STM-AN3 (data not shown). The sequence was assessed for putative open reading frames. A putative open reading frame (oifl) was found, and a Blastx search was perform ed. The sequence was 100% homologous to a hypothetical protein from Ralstonia solanaceamm (accession num ber AL646052.1) (42) . Analysis of other putative open reading frames (or/2 and oif3) revealed significant amino acid matches (99% and 100%, respectively) to other hypothetical Ralstonia pickettii proteins.
Expression profiles of PBE and CBE strains. A comparison of the expression profiles of the recom binant constructs was perform ed. The expression of N rdF and Adh from STMl(pJLA 507-A N ) is presented in Fig. 3 . SDS-PAGE revealed a 1822 M A TIC E T AL. protein with an apparent m olecular mass of 36 kD a evident 1 h postinduction (data not shown). W estern blot analysis showed that the protein reacted with polyclonal Adh antiserum. Ex pression of the 11-kDa C term inus of N rdF was not apparent using SDS-PAGE (data not shown). However, W estern blot ting with polyclonal N rdF antiserum detected the expression of an 11-kDa band, confirming the expression of N rdF in STMl(pJLA507-AN).
The expression profiles of the CBE strains are also displayed in Fig. 3 . N either Adh nor N rdF expression could be visualized using SDS-PAGE with Coomassie brilliant blue (data not shown). W estern blot analysis with polyclonal A dh antisera revealed the presence of a 36-kDa band corresponding to the correct mass of Adh in all CBE strains, with the exception of STM-sspA (data not shown). N rdF expression was faintly de tected in the majority of the CBE strains, indicating that ex pression of N rdF was occurring but that the level of expression was at the very limit of detection (data not shown).
In vitro growth and stability of expression. Growth curves of the CBE and PBE strains were perform ed to determ ine w hat effect the genetic manipulations had on the various strains' abilities to replicate in vitro (Fig. 3) . The PBE strains were grown at mid-log phase for 1 h before induction at 42°C. Shortly after induction, two of the PBE strains, STMl(pJLA 507-N ) and STM-1 (pJLA507-AN), had static levels of growth. Both of the strains express N rdF, suggesting that the production of N rdF had a growth-inhibitory effect on STM-1. CFU counts were conducted, which confirmed that the over expression of N rdF had a bacteriostatic effect on STMl(pJLA 507-N ) and STM-1 (pJLA507-AN) (data not shown).
Growth curves of the CBE strains were perform ed in mini mal medium supplem ented with aromix to ensure that the insertion of the nrdF-adh operon into the chromosome of STM-1 did not further attenuate the strains. Analysis of growth revealed th at one strain, STM-AN1, replicated at a much lower rate than the other strains (Fig. 3) . This indicated that the insertion of the nrdF-adh operon into the dps gene attenuated the growth of this strain in minimal medium, making it unsuit able for subsequent vaccination trial experiments.
The stability of antigen expression from the various PBE and CBE strains in vivo was examined. Mice were orally inoculated with 1 X 109 CFU, and the spleens were harvested 10 days postinoculation. Fifty colonies (10 p er mouse) were randomly selected for each strain and analyzed by Southern blotting for the presence of the operon and by W estern blotting for h eter ologous antigen expression (Table 2) . Colonies were not de tected in the spleens for any of the PBE strains or STM-AN2. The nrdF-adh operons in colonies th at were detected for all other CBE strains showed 100% stability, and all colonies examined were capable of heterologous antigen expression.
Immune responses of mice following oral vaccination. Mouse oral vaccination trials were conducted using the PBE and CBE strains. Mice were given either three oral imm uni zations with S. enterica serovar Typhimurium strains or three intraperitoneal vaccinations with purified A dh or NrdF. F our teen days after the final vaccination, five mice in each group were sacrificed (day 42). As M. hyopneumoniae is not capable of infecting mice, immune recall was tested using purified recom binant antigens. Two weeks later, the remaining five mice were intranasally challenged with purified A dh and NrdF. Serum and lung wash responses were determ ined using ELISA (Fig. 4) . Statistically significant (P < 0.05) serum IgM re sponses against Adh, N rdF, and STM-1 whole cells were de tected for all CBE and purified intraperitoneal antigen mice at 
In vivo stability determined by orally inoculating groups of five mice with 1 : 109 CFU of a single strain. Ten days after inoculation, the spleens were removed. S. enetrica serovar Typhimurium aroA was selected by plating homogenized spleens onto Rif LB agar (STM-sspA) or Sm LB agar (all other strains). Colonies were confirmed as S. enterica serovar Typhimurium by streaking them onto MacConkey agar. Ten colonies per mouse were randomly selected for further analysis.
b ND, no data. day 42, but not day 70. No IgM response against A dh or N rdF was detected among PBE mice, although there was an IgM STM-1 whole-cell response at day 42 (data not shown). Serum IgG responses against N rdF and Adh are shown in Fig. 4 . A t day 42, only the purified-intraperitoneal-antigen-and STMsspA-vaccinated mice had significant IgG responses (P < 0.05) against A dh and NrdF. A fter intranasal challenge (day 70), all of the CBE and intraperitoneally vaccinated mice displayed significant serum IgG responses (P < 0.05) against both anti gens, indicating that a systemic response had been induced. A serum IgG response against A dh or N rdF could not be de tected at any time point for the PBE mice, although an IgG response against STM-1 whole cells was detected. The lung wash samples from the mice were analyzed for the presence of N rdF-and Adh-specific IgA and IgG; however, no significant response was detected at any time point (data not shown). Pooled sera from orally immunized mice prior to intranasal challenge (day 42) were used in a W estern blot against M. hyopneumoniae (strain J) whole-cell lysate, purified Adh, and purified N rdF (Fig. 4) . The antiserum recognized a protein of approximately 95 kD a in the M. hyopneumoniae whole-cell lysate, which corresponds to the m ature adhesin protein (27, 50) . The antiserum also recognized the adhesin cleavage p ro d ucts, displaying the characteristic ladder p attern previously ob served (28, 50, 53) . This antiserum recognized a protein cor responding in mass to full-length N rdF (42 kD a) in the M. hyopneumoniae whole-cell lysates (15) . The antiserum recog nized both of the purified antigens, indicating th at oral im m u nization of mice with S. enterica serovar Typhimurium is capa ble of eliciting specific serum IgG responses against both of the antigens.
DISCUSSION
O ral vaccination of recombinant, attenuated live bacterial expression systems is a promising m ethod for heterologous antigen delivery. In this study, CBE of M. hyopneumoniae an tigens in aroA-attenuated S. enterica serovar Typhimurium elicited significant systemic immune responses. This approach to vaccine design has a num ber of advantages that allow it to be used for commercial applications. They include the use of non-antibiotic resistance markers, a stable expression system, low cost of production, and easy administration.
The PBE system used in this study failed to elicit any signif icant antigen-specific immune responses. Induction of expres sion in the PBE system was perform ed at 42°C so th at the PBE strains would be loaded with overexpressed antigens upon ad ministration. This is in contrast to the CBE strains, which expressed N rdF and A dh in vitro at much lower levels. N one theless, the CBE strains did elicit significant systemic (IgG and IgM) responses in vivo. Lowering the level of heterologous antigen expression may reduce the physiological stress on the host Salmonella strain, thus increasing the level o f colonization and immune response (46) . Colonies were not detected after 10 days of passage in vivo for any o f the PBE strains examined. Expression of the antigens and the extra metabolic burden associated with maintaining the plasmid in vivo appear to have severely im pacted the abilities of these strains to survive in the murine spleen, which also may have contributed to the lack of an antigen-specific immune response. D unstan et al. (13) ex amined the abilities of aroA-and aroD -attenuated S. enterica serovar Typhimurium harboring a range of tetanus toxin frag m ent C-expressing plasmids to survive in various murine o r gans after a single inoculation. The authors found colonies in the spleen up to 20 days postinoculation for all vectors exam ined, although they used an inoculum 10-fold greater than those examined here. This, along with the choice of plasmid vector, may have contributed to these contrasting results.
Overexpression of N rdF in the PBE strains had a bacterio static effect on S. enterica serovar Typhimurium, which most likely would have had a negative impact on its ability to invade and replicate in vivo. Such a bacteriostatic effect has been 1824 M A TIC E T AL. shown during the expression of a Mycoplasma arthritidis super antigen (10) , which decreased the viability of the host E. coli cells. Therefore the results presented in this study suggest that the ability of live, aroA -attenuated S. enterica serovar Typhimurium-based vaccines to replicate and express stably in vivo is more im portant than the level of antigen expression at im m u nization in generating systemic immune responses.
Characterization of STM-AN1 revealed the presence of the nrdF-adh operon within the dps gene, dps encodes a D NA binding protein that provides starvation-induced resistance to hydrogen peroxide, and expression is upregulated when Sal monella comes under oxidative stress during invasion of m ac rophages (22, 30) . In E. coli, dps transcription is regulated in a sigma S-and IH F-dependent m anner, and the IH F protein has been shown to bind upstream of the dps prom oter (3) . In this study, insertion of the nrdF-adh operon into dps further atten uated STM-AN1 in minimal medium supplem ented with aro mix. Given this result and the im portance of dps during m ac rophage invasion, STM-AN1 was not used in the vaccine trial.
The nrdF-adh operon in STM-AN2 was inserted into glgP. This was the only CBE strain for which colonies could not be detected in the murine spleen 10 days after in vivo passage. Previous infection studies in chickens with a glycogen m utant S. enterica serovar Typhimurium had shown that glycogen m e tabolism has a minor role in colonization and pathogenesis but a more significant role in survival (36) ; this observation agrees with our findings. In this experiment, dual attenuation of aroA and glgP reduced the ability of S. enterica serovar Typhimurium to survive in vivo. Control of the glycogen metabolism pathway is thought to be allosterically regulated by ADP-glucose pyrophosphorylase (40) . In E. coli, the binding of CsrA to glgCAP transcripts prom otes glgCAP m RNA degradation, which inhib its glycogen metabolism (4) . Transcriptional regulation of the operon in E. coli also appears to be controlled by RpoS (23). R ecent microarray data suggest the glgP transcript was downregulated during Salmonella intracellular infection of murine macrophages, although it was below the significant threshold value (14) . D espite this observation and the reduced ability of STM-AN2 to survive in the spleen, it was still able to elicit an antigen-specific IgG response. The position of the nrdF-adh operon in STM-AN3 was able to be identified; however, the sequence did not match any known Salmonella sequence. The putative open reading frame (oifl) driving expression of the antigens had 100% amino acid homology to a hypothetical protein from the plant pathogen R. solanacearum (42) and a 99% match to a hypothetical protein from the hum an pathogen R. pickettii. Analysis of the trans lated sequence using the Pfam and Expasy databases revealed no matches with known proteins. As this sequence has not previously been reported in Salmonella, and given the strain's ability to survive in vivo, it is unlikely to be critical for p atho genesis.
STM-AN4, which contains the nrdF-adh operon inserted within the conjugal-transfer gene tral, displayed significant IgG titers after intranasal challenge, tral encodes OriT nickase/ helicase (34) and catalyzes the unwinding of the D N A duplex while also acting as a sequence-specific D N A transesterase that provides the site/strand-specific nick required to initiate D NA transfer (32) . M icroarray analysis perform ed on the S. enterica serovar Typhimurium transcriptom e during intracellular infec tion of murine macrophages did not examine tral transcript levels; however, the conjugal-transfer genes on either side (trbH and traX) both displayed significantly elevated transcript levels (14) , suggesting that tral may also be upregulated during in vivo infection.
The importance of in vivo expression is further highlighted by the fact that STM l-sspA, which is upregulated in vivo (48) , produced the only statistically significant CBE-generated re sponse at day 42 against either Adh or NrdF. The expression of sspA in E. coli is induced during stationary phase while the bacterium is undergoing starvation for either carbon, amino acids, nitrogen, or phosphate (49) . It has been previously dem onstrated that S. enterica serovar Typhimurium aroA, express ing tetanus toxoid under the control of either single-copy (chromosomal) or multicopy (plasmid) sspAp, can generate significant immune responses in mice (48) . The use of in vivoinducible prom oters for S. enterica serovar Typhimurium ex pression of heterologous antigens appears to be a promising approach, with the use of other prom oters, such as ssaGp and pagCp, increasing the immunogenicity of heterologous anti gens in murine models in comparison to native constitutive prom oters (13, 35) .
The strains capable of surviving for 10 days in vivo all dis played 100% stability of the nrdF-adh operon. Husseiny and H ensel (26) reported that integration of a heterologous anti gen into purD of S. enterica serovar Typhimurium was stable after 9 days in vivo; however, they did not report w hether the colonies were still capable of expression. All recovered colo nies examined in this experim ent were capable of heterologous antigen expression, dem onstrating th at the integrated operon was highly stable.
Previous studies were conducted using attenuated S. enterica serovar Typhimurium aroA to express single N rdF (7, 16, 17) or A dh (8 ) antigens. Fagan et al. (16) orally immunized mice with aroA-attenuated S. enterica serovar Typhimurium SL3261 expressing N rdF from pHSG398. This construct elicited N rdFspecific serum IgA and secretory IgA but failed to produce a significant serum IgG response. Chen et al. (7) expressed N rdF using plasmid-based prokaryotic and eukaryotic expression vectors in S. enterica serovar Typhimurium aroA CS332, and they failed to elicit a hum oral immune response in orally vac cinated mice. However, the splenocytes from the mice p ro duced a significant level of IFN -7 when stim ulated with NrdF, indicating the induction of a cell-mediated immune response (7) . The varying results from this work and the previous trials indicate the importance of the choice of expression system and Salmonella strain for immunization purposes.
This study has dem onstrated the ability of native Salmonella prom oters to stably express heterologous, single-copy antigens from the chromosome and to generate systemic immune re sponses via the oral immunization route. The main advantages of this technique are th at it can be used to generate immune responses against bacteriostatic antigens and can do so w ithout the use of antibiotic resistance markers. The integration of the heterologous expression operon into the S. enterica serovar Typhimurium chromosome via a prom oter-trapping technique allows many novel prom oters and attenuation sites to be si m ultaneously assessed. This technique also allows the produc tion of stable, cheap, easily adm inistered vaccines that may be used in a commercial setting.
